IL-6 is elevated in the serum of patients with NMO (Uzawa et al., 2010; Barros et al., 2016) and is positively correlated with disease severity (Matsushita et al., 2013) and AQP4-IgG levels (Uzawa et al., 2010). Here, IL6 is linked to neuromyelitis optica.